Many documents clarified the mechanisms of KRAS driving cancers, in which KRAS keeps switching between the active GTP-bound form and the inactive GDP-bound form [45], the miscellaneous KRAS mutations widely existed maintains signaling constantly activated and stimulates cells’ proliferation, survival and metastasis then promotes the development of carcinomas [46]. The gene discussed is KRAS; the disease is carcinoma.